|
|
Volumn 111, Issue 3, 2000, Pages 726-732
|
|
Antenatal screening for fetomaternal alloimmune thrombocytopenia: An evaluation using the criteria of the UK National Screening Committee
a,c
|
|
Author keywords
Alloimmune; Antenatal; Fetomaternal; Screening; Thrombocytopenia
|
|
Indexed keywords
ANTIGEN;
HPA 1A ANTIGEN;
IMMUNOGLOBULIN G;
UNCLASSIFIED DRUG;
ADULT;
ANAMNESIS;
ANTIGEN DETECTION;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
EARLY DIAGNOSIS;
FEMALE;
FETUS BLOOD SAMPLING;
HIGH RISK POPULATION;
HUMAN;
IMMUNOMODULATION;
LATENT PERIOD;
MAJOR CLINICAL STUDY;
NEWBORN;
NEWBORN HEMOLYTIC DISEASE;
PRENATAL SCREENING;
PREVALENCE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RELIABILITY;
REVIEW;
SAFETY;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
UNITED KINGDOM;
VALIDATION PROCESS;
ANTIGENS, HUMAN PLATELET;
FEMALE;
FETAL DISEASES;
GREAT BRITAIN;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
INCIDENCE;
INFANT, NEWBORN;
ISOANTIBODIES;
MASS SCREENING;
PREGNANCY;
PRENATAL DIAGNOSIS;
SENSITIVITY AND SPECIFICITY;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 0034494717
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2000.02254.x Document Type: Review |
|
Times cited : (43)
|
|
References (33)
|
